PureTech Health announced the appointment of Robert Lyne as chief portfolio officer. Lyne brings a decade of experience in international life science deals and portfolio management, along with governance and executive team leadership experience. Robert is expected to join PureTech by early January 2024. Lyne joins PureTech from Arix Bioscience.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTC:
